Goldman Sachs’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $4.42M | Buy |
|
|||||
|
2023
Q3 | $1.52M | Sell |
|
|||||
|
2023
Q2 | $1.49M | Sell |
|
|||||
|
2023
Q1 | $1.78M | Sell |
|
|||||
|
2022
Q4 | $13.3M | Buy |
|
|||||
|
2022
Q3 | $15.2M | Sell |
|
|||||
|
2022
Q2 | $164M | Buy |
|
|||||
|
2022
Q1 | $10.6M | Sell |
|
|||||
|
2021
Q4 | $34.2M | Buy |
|
|||||
|
2021
Q3 | $34.7M | Buy |
|
|||||
|
2021
Q2 | $28.8M | Sell |
|
|||||
|
2021
Q1 | $70.8M | Sell |
|
|||||
|
2020
Q4 | $105M | Sell |
|
|||||
|
2020
Q3 | $93M | Buy |
|
|||||
|
2020
Q2 | $43.3M | Sell |
|
|||||
|
2020
Q1 | $34.2M | Buy |
|
|||||
|
2019
Q4 | $41.4M | Sell |
|
|||||
|
2019
Q3 | $27.4M | Buy |
|
|||||
|
2019
Q2 | $29.5M | Sell |
|
|||||
|
2019
Q1 | $22.4M | Buy |
|
|||||
|
2018
Q4 | $3.29M | Sell |
|
|||||
|
2018
Q3 | $4.55M | Buy |
|
|||||
|
2018
Q2 | $2.33M | Sell |
|
|||||
|
2018
Q1 | $5.23M | Buy |
|
|||||
|
2017
Q4 | $591K | Buy |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $359K | Buy |
|
|||||
|
2017
Q1 | $54K | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $450K | Buy |
|
|||||
|
2016
Q2 | $203K | Buy |
|
|||||
|
2015
Q1 | – | Sell |
|
|||||
|
2014
Q4 | $506K | Sell |
|
|||||
|
2014
Q3 | $642K | Sell |
|
|||||
|
2014
Q2 | $997K | Buy |
|
|||||
|
2014
Q1 | $542K | Buy |
|
|||||
|
2013
Q4 | $446K | Sell |
|
|||||
|
2013
Q3 | $517K | Buy |
|